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ABSTRACT
Objectives: We compared 2 sociocultural cohorts
with different duration of exposure to graphic health
warning labels (GHWL), to investigate a possible
desensitisation to their use. We further studied how a
differing awareness and emotional impact of smoking-
associated risks could be used to prevent this.
Setting: Structured interviews of patients from the
general respiratory department were undertaken
between 2012 and 2013 in 2 tertiary hospitals in
Singapore and London.
Participants: 266 participants were studied, 163
Londoners (35% smokers, 54% male, age 52±18 years)
and 103 Singaporeans (53% smokers, p=0.003; 78%
male, p<0.001; age 58±15 years, p=0.012).
Main outcomes and measures: 50 items assessed
demographics, smoking history, knowledge and the
deterring impact of smoking-associated risks. After
showing 10 GHWL, the impact on emotional response,
cognitive processing and intended smoking behaviour
was recorded.
Results: Singaporeans scored lower than the
Londoners across all label processing constructs, and
this was consistent for the smoking and non-smoking
groups. Londoners experienced more ‘disgust’ and felt
GHWL were more effective at preventing initiation of, or
quitting, smoking. Singaporeans had a lower awareness
of lung cancer (82% vs 96%, p<0.001), despite ranking
it as the most deterring consequence of smoking.
Overall, ‘blindness’ was the least known potential risk
(28%), despite being ranked as more deterring than
‘stroke’ and ‘oral cancer’ in all participants.
Conclusions: The length of exposure to GHWL
impacts on the effectiveness. However, acknowledging
the different levels of awareness and emotional impact
of smoking-associated risks within different
sociocultural cohorts could be used to maintain their
impact.
INTRODUCTION
Smoking remains a global public health issue
with a total prevalence of 21%. Thirty-six
per cent of men and 7% of women currently
smoke.1 It is the leading cause of morbidity
and mortality in almost every country in the
world,2 causing over six million deaths per
year and accounting for 16% of all-cause
mortality in men and 7% in women globally.3
In addition, the use of e-cigarette products
and advertisements is currently on the rise.4
In recognition of the global epidemic of
tobacco use, the WHO instigated the
Framework Convention on Tobacco Control
(FCTC) and the 168 adopting countries were
obliged to introduce ‘large, clear, visible and
legible’ health warnings on cigarette
packages.5
Cigarette packets remain a powerful mar-
keting tool for the tobacco industry, creating
brand awareness and inﬂuencing views on
safety and perception of taste.6 Tobacco com-
panies are predicted to spend more money
on e-cigarette advertising in 2 days than the
current total US annual budget on smoking
and tobacco cessation education.7 Graphic
health warning labels (GHWL) are pictorial
graphic images that appear on the front of
cigarette packages. They depict advanced
stages of speciﬁc diseases, with accompanying
Strengths and limitations of this study
▪ Cross-sectional cohort studies demonstrate
associations and cannot be used to wholly deter-
mine causality.
▪ Demographic differences between the London
and Singapore cohorts.
▪ Linear regression analysis showed that the
primary outcome of ‘desensitisation’ was inde-
pendent of other demographic variables, includ-
ing ethnicity.
▪ Participants were recruited from outpatient set-
tings and the findings should be interpreted with
caution.
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messages, and can be used to educate the public,
serving as healthcare advice to impact on smoking pre-
vention and cessation8 both in smokers and non-smokers
alike.9
GHWL have several advantages over text-only labels;9–14
they increase viewing time, attention, as well as the recall
of messages,15 and they increase intention and motiv-
ation to quit smoking.11 13 They can also modify health
beliefs about the dangers of smoking,16 17 and recent
studies have shown that they are more effective in redu-
cing cravings to smoke, particularly among adolescent
smokers.18 19
In 2004, Singapore had become the ﬁrst country in
Asia to introduce GHWL,20 prior to the implementation
of the FCTC. In 2008, the UK was the ﬁrst European
country to introduce GHWL on all tobacco packaging as
a direct result of the European Commission labelling
directive.21
This study aimed to investigate whether an increased
duration of exposure to GHWL leads to a desensitisation
of their impact, hypothesising a reduction in the cogni-
tive processing domain. A number of studies until now
have explicitly investigated a habituation to cigarette
warning labels over time;22–25 however, none have
explored this relation in the context of different cultural
cohorts. Understanding cultural differences in their
responses to speciﬁc labels, and using these differences,
may prove an effective way to prevent desensitisation.
PATIENTS AND METHODS
Data were acquired at Guy’s and St Thomas’ National
Health Service (NHS) Foundation Trust, London, UK
and at Singapore General Hospital, Singapore, during a
1-year period starting January 2012. Participants were
recruited from respiratory department outpatient clinics
within both hospitals. Written informed consent was
obtained from all participants. We included male and
female smokers and non-smokers who could communi-
cate ﬂuently and were aged between 21 and 80 years.
Patients who were unable to consent, view the GHWL or
understand the survey were excluded from the study.
In both countries, participants answered the questions
in English, but Chinese-only speaking participants had
the questions translated. Ex-smokers who had quit
within the past 2 years were excluded from the analysis
to allow a better comparison between smokers and non-
smokers. At the time of the study, participants in
Singapore had been exposed to GHWL for 8 years, twice
as long as the London cohort (4 years). Some of the
data on the London cohort, comparing smokers with
non-smokers and patients with chronic obstructive pul-
monary disease (COPD), had been published in parts
elsewhere.26
Structured survey
A structured survey containing 50 items based on previ-
ous studies was used for this study.26–29 The items were
generated following an internal peer review among two
tertiary hospitals (Guy’s and St Thomas’ Hospital, London,
UK; and Singapore General Hospital, Singapore), and the
Academic Health Sciences Centre (King’s Health Partners,
London, UK) with its associated academic institution
(King’s College London, UK).
The survey recorded demographics, smoking history
and the perceived impact of smoking on health on a con-
tinuous scale from 1 (no effect) to 10 (maximum effect).
It also recorded knowledge of speciﬁc smoking-associated
health risks: ‘Do you believe the following diseases are
related to smoking? (yes/no/not sure): “mouth and
throat cancer”, “lung cancer”, “heart disease”, “stroke”
and “blindness”’. The deterring impact for each risk was
assessed by asking participants which disease they would
‘prevent’, if they could only choose one; and which they
would ‘treat’, if only one could be treated.
Participants were then shown 10 UK and Singapore
GHWL with similar messages, consisting of: ‘oral
cancer’, ‘neck cancer’, ‘mouth disease’, ‘lung cancer’,
‘lung disease’, ‘heart attack’, ‘heart disease’, ‘stroke’,
‘miscarriage’ and ‘harms the baby’. After viewing the
labels, the participants’ emotional response to the labels
was recorded by asking them to state whether they felt
‘fear’, ‘disgust’ or whether they ‘avoided looking at the
labels’ (yes/no).
Participants’ processing of the warning labels was also
recorded regarding (1) package processing and (2)
general processing (on a scale of 1 ‘not at all/never’ to
5 ‘all the time/a lot’).
Sample size analysis
A sample size calculation revealed that at least 200 parti-
cipants were required, with 50 participants needed in
each group of the study (smokers and non-smokers, in
both cities) to achieve a power of >0.8, based on a 95%
CI and an α of 0.05. The estimated label processing dif-
ference, measured from 1 ‘not at all/never’ to 5 ‘all the
time/a lot’, was 1 out of 5 between the non-smoker
groups (least expected difference compared with the
smoker groups), with a maximum estimated population
variance of 3–4, assumed to be the same in both cities.
Statistical analysis
Data were collected using MS Excel 2007 (Microsoft
Corporation, Seattle, Washington, USA) and analysed
with SPSS statistics V.22 (IBM, New York, New York, USA).
The Shapiro-Wilk test was used to assess data for norma-
lity. Normally distributed categorical data were assessed
using the χ2 test, and unpaired t-tests for non-categorical
data. Non-normally distributed data were assessed
using Spearman’s coefﬁcient, Mann-Whitney and the
Kruskal-Wallis test. Where multiple correlations were
found to be associated with the main outcome measures
of knowledge score (ie, the number of risks that each par-
ticipant was aware of), emotional response and depth of
processing of the health warnings, multiple linear regres-
sion analyses were applied to determine independent
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factorial associations. The independent variables
included in the regression analysis were age, gender, sex,
ethnicity, smoking and city status (London vs Singapore).
A level of signiﬁcance was deﬁned as a p<0.05.
RESULTS
Demographics
A total of 266 participants were included in the study,
163 from London and 103 from Singapore. Participants
from Singapore were predominantly ‘Chinese’ (71%) or
‘Asian/Asian other’ (27%) which includes people of
Indian and Malay ethnicities. London respondents were
predominantly ‘white’ (79%), ‘Asian/Asian British’
(10%) and ‘black/black British’ (9%). The London
group was younger, with more male participants and a
lower percentage of smokers. The ethnic background
was different between the two groups, but typical of the
two cities (table 1). The participants were matched for
age (p=0.147) when comparing the smoking groups.
The non-smoking groups were matched with regard to
percentage of ex-smokers: 19 (40%) in Singapore, versus
41 (37%) in London (p=0.915; refer to online
supplementary tables E1 and E2 for more detailed infor-
mation on smoker and non-smoker demographic).
Perceived effect of smoking on health
Overall, non-smokers perceived smoking as more
harmful than smokers (8.6±2.2 vs 7.7±2.4 points,
p=0.001), while Londoners felt that smoking was more
harmful than Singaporeans (8.8±1.7 vs 7.2±2.8 points,
p<0.001), which was reﬂected in the results of the
smokers (8.4±1.8 vs 6.9±2.7 points, p<0.001) and non-
smoker groups (9.1±1.7 vs 7.6±2.9 points, p<0.012).
Awareness of health risks associated with smoking
Participants had the lowest awareness of the association
between smoking and ‘blindness’, and were most aware
of ‘lung cancer’ as a risk, followed by ‘mouth and throat
cancer’, ‘heart disease’ and ‘stroke’. Smokers in
Singapore were more aware of ‘blindness’ than smokers
in London (p=0.031). Non-smokers in Singapore were
less aware of ‘mouth and throat cancer’ and ‘lung
cancer’ as a consequence of smoking than non-smokers
in London (table 2).
Ethnicity was correlated with the total knowledge
score of the smoking-related diseases (see online
supplementary table E3), with Chinese participants being
better informed overall than Caucasian participants (see
online supplementary table E4); however, regression ana-
lyses showed that the signiﬁcant differences in overall
knowledge score between both cities were independent
of the different ethnicity levels, age, gender, occupation
and the levels of smokers and non-smokers in those cities
(table 3).
Deterrent impact of smoking-associated risks
When participants were asked to choose one of the
listed diseases that they could prevent or treat, ‘lung
cancer’ was the most common choice, followed by ‘heart
disease’, ‘blindness’, ‘stroke’ and ‘mouth and throat
Table 1 Demographic data of participants
Total (n=266) London (n=163) Singapore (n=103)
χ2/one-way
ANOVA (p value)
Age, mean (SD) 54.4 (16.8) 52.4 (17.9) 57.7 (14.5) 0.012
Male, n (%) 168 (63) 88 (54) 80 (78) <0.001
Female, n (%) 98 (38) 75 (46) 23 (22)
Smokers, n (%) 112 (42) 57 (35) 55 (53) 0.003
Chinese 73 (27) 0 (0) 73 (71) <0.001
White 129 (48) 129 (79) 0 (0) <0.001
Asian/Asian other 45 (17) 17 (10) 28 (27) <0.001
Black/black other 14 (5) 14 (9) 0 (0) 0.002
Mixed 5 (2) 3 (2) 2 (2) 0.953
ANOVA, analysis of variance.
Table 2 Percentage of participants showing awareness of smoking consequences: London (L) and Singapore (S), by
smoking status
All Non-smokers Smokers
L S p Value L S p Value L S p Value
Heart disease, n (%) 138 (85) 76 (74) 0.029 86 (81) 33 (70) 0.134 51 (89) 43 (78) 0.104
Stroke, n (%) 116 (71) 66 (64) 0.226 73 (69) 29 (62) 0.386 42 (74) 37 (67) 0.457
Blindness, n (%) 39 (24) 35 (34) 0.075 26 (25) 12 (26) 0.895 13 (23) 23 (42) 0.031
Mouth and throat cancer, n (%) 147 (90) 79 (77) 0.003 97 (92) 36 (77) 0.012 49 (86) 43 (78) 0.282
Lung cancer, n (%) 156 (96) 84 (82) <0.001 102 (96) 36 (77) <0.001 53 (93) 48 (87) 0.310
Bold typeface denotes statistical significance.
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cancer’. Among smokers, ‘blindness’ ranked second
behind ‘lung cancer’. Londoners, overall, chose ‘mouth
and throat cancer’ more so than Singaporeans, and non-
smokers in London were more likely to select ‘blind-
ness’. In Singapore, smokers were more likely to
select ‘stroke’ and non-smokers to choose ‘lung cancer’
(table 4). Overall, 45% of respondents felt that GHWL
were a sufﬁcient motivation to quit, or prevent from
starting smoking, with more Londoners and more non-
smokers in agreement (ﬁgure 1).
Emotional response to GHWL
Following exposure to GHWL, 52% of all participants
said that they experienced ‘fear’, 69% felt ‘disgust’ and
29% said they would avoid looking at the labels.
Londoners, overall, were more likely to experience
‘disgust’ than Singaporeans, and this was consistent
when comparing both smokers and non-smokers. There
were no differences in the experience of ‘fear’ or ‘avoi-
dance’ (table 5).
While the feeling of ‘disgust’ was greater in speciﬁc
ethnic groups (see online supplementary table E3),
regression analyses revealed that the signiﬁcant differ-
ence in ‘disgust’ between London and Singapore was
independent of the ethnic make-up of both cities, in addi-
tion to age, gender, occupation, and the levels of
smokers and non-smokers in each country (table 3).
Overall, more non-smokers experienced ‘fear’ and
‘disgust’ than smokers (see online supplementary table
E6 for more detailed information).
Cognitive processing of GHWL
Smokers and non-smokers in London showed a higher
degree of label processing compared with their
Singaporean counterparts (table 6). Overall, non-
smokers talked more about GHWL than smokers, but no
other signiﬁcant differences in processing were found
between them (refer to online supplementary table E7
for more detailed information).
DISCUSSION
This is the ﬁrst study comparing the effect of GHWL
across different cultures, Singapore versus London, and
revealing a desensitisation effect to GHWL over time, as
deﬁned by diminished cognitive processing. Cultural dif-
ferences were found in the response to various GHWL.
Though the FCTC appreciates the need to refresh
labels,30 policies do not exist which recognise the
importance of cultural differences to focus any label
refresh in order to prevent desensitisation.
During the study, Singaporeans have had exposure to
GHWL for twice as long as Londoners and they dis-
played less ‘disgust’ and decreased processing of the
health messages. These ﬁndings were independent of
differences in the ethnicity, gender differences, occupa-
tion status and the levels of smokers and non-smokers in
each county.
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Signiﬁcant differences in label processing were also
found between non-smokers in London and Singapore,
stressing the importance of GHWL for opposing
smoking within the entire population, not just smokers.
Consequently, this implies that non-smokers are prone
to the same desensitisation effects as smokers and these
ﬁndings raise the question as to how GHWL efﬁcacy is
best maintained.
Clinical significance
Our ﬁndings are consistent with previous descriptions of
an exposure–affect relationship with health advertise-
ments31–33 and a prognosticated ‘wear out’ effect. White
et al24 showed that the cognitive processing among ado-
lescents diminishes after 5 years, while other studies
have shown the impact of GHWL ‘wear out’ after
around 3 years, with differences existing between cul-
tures.25 34 Exposure to new messages is processed more
extensively than to well-known messages.35 36 Increased
conﬁdence surrounding messages, which is expected
with greater familiarity, is also known to foster heuristic
models of cognitive processing37 38 and less systematic
processing of labels.39 Similar observations have been
described in patients with COPD,26 although COPD is
associated with cognitive and psychological biases that
favour diminished processing.29 40–44 This study,
however, reaches the same conclusion by comparing two
separate cohorts with different exposure to GHWL.
Knowledge of adverse consequences of smoking
Knowledge of smoking-associated risks varies widely. A
study comparing 21 European countries found consider-
able differences in the awareness that heart conditions
are associated with smoking.45 This study observed that
Singaporeans were less aware of the association with
‘mouth and throat cancer’, ‘heart disease’ and ‘lung
cancer’ than Londoners. One-ﬁfth of Singaporeans were
unaware of smoking being associated with lung cancer
Table 4 Combined percentage of participants who chose to prevent and treat each health risk when only one could be
chosen: London (L) versus Singapore (S) overall, and by smoking status
All Non-smokers Smokers
S L p Value S L p Value S L p Value
Heart disease (%) 18 22 0.251 19 25 0.301 17 18 0.957
Stroke (%) 12 7 0.046 12 9 0.544 13 3 0.004
Blindness (%) 13 18 0.111 6 17 0.013 18 19 0.831
Mouth and throat cancer (%) 1 9 <0.001 0 9 <0.001 2 7 0.060
Lung cancer (%) 50 43 0.103 61 39 <0.001 41 50 0.172
Bold typeface denotes statistical significance.
The individual ‘prevent only one’ and ‘treat only one’ table is available in the online supplementary table E5.
Figure 1 Percentage of
participants (%) who felt graphic
health warning labels are
sufficient motivation to help them
stop/not start smoking.
Comparing London and
Singapore and non-smokers with
smokers in each city. *p≤0.05,
***p≤0.001.
Table 5 Percentage of participants who had an emotional reaction after viewing the graphic warning labels: London (L) and
Singapore (S) overall, and by smoking status
All Non-smokers Smokers
Response n (%) S L p Value S L p Value S L p Value
Experienced fear 50 (49%) 87 (53%) 0.443 30 (64%) 65 (61%) 0.768 19 (35%) 22 (39%) 0.656
Experienced disgust 55 (53%) 128 (79%) <0.001 30 (64%) 84 (79%) 0.044 45 (45%) 43 (75%) 0.001
Avoiding looking at
labels
29 (28%) 47 (29%) 0.905 13 (28%) 28 (26%) 0.873 16 (29%) 18 (32%) 0.775
Bold typeface denotes statistical significance.
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and it is noteworthy that the message that ‘smoking
causes lung cancer’ was removed from Singaporean
labels in 2005, with ‘smoking causes lung disease’ intro-
duced in 2013.46 This observation indicates that public
health campaigns can potentially have a signiﬁcant
impact on public awareness.
‘Blindness’ was the least well-known risk despite
having the second most deterring effect in smokers, as
previously shown.47 The European Commission only ofﬁ-
cially approved a new warning ‘smoking causes blind-
ness’ in 2012. It will be placed on cigarette packaging in
the UK in 2016; although Singapore has introduced this
warning in 2013, a large proportion of countries around
the world have not included ‘blindness’ as a message on
their packaging.46
Limitations of study
This paper is quasi-clinical in nature, and though there
was an inability to critically analyse the population in
their context and cultural norms, its strength is that it
allows us, and policymakers, to speculate regarding why
groups are different, why not and how long they should
expose speciﬁc populations to GHWL before refreshing
them—questions that have not yet been asked. We
observed a signiﬁcant difference in label processing at 8
vs 4 years and encourage policymakers to review their
guidelines with these questions in mind, at least every
4 years.
Data were collected by means of a cross-sectional struc-
tured survey and the results should not be generalised
to the general population per se. Participants were
recruited from outpatient hospital settings, and hence a
selection bias may have further inﬂuenced generalisabi-
lity. A number of warning labels were shown over a short
period of time and this might have perpetuated the
expected emotional response. In addition, while the
emotional response and cognitive processing questions
were simple and applicable to everyday life, they lacked
evidence of reliability and validity.
The Singaporean participants were older and had a
higher proportion of smokers compared with the
London cohort. Increased age was associated with
decreased depth of processing and ‘fear’, but not
‘disgust’ or ‘avoidance’. However, our outcomes
remained consistent when comparing just the smoking
groups between both cities, where Singaporean and
London smokers were matched for age. Outcomes were
also conﬁrmed when comparing the non-smoker
groups. Further, the regression analyses showed inde-
pendent differences between Singapore and London in
‘disgust’ and ‘label processing’, irrespective of other
demographic variables (age, gender, ethnicity, occupa-
tion and smoking status).
Except for age and smoking status, other cultural dif-
ferences may not have been accounted for in our ana-
lysis; hence, a more in-depth cultural and social analysis
may be required in future work. While cultural differ-
ences may impact on the emotional response to labels,
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they would not impact on cognitive processing of labels
or the primary outcome of desensitisation.
CONCLUSION
Desensitisation appears to occur with an increased
length of exposure to GHWL. Previous studies have also
implicated a habituation to the initial impact of GHWL
over a period of weeks22 and others have implicated a
‘wear out’ effect over years.23 24 In addition, while
studies have also compared the effect of GHWL among
different countries,25 to the best of our knowledge,
none have directly investigated the sociocultural rele-
vance of the impact of desensitisation.
Current interest resides in a move towards plain ciga-
rette packaging which removes branding and other dis-
tractors from the core messages presented.48 Culturally
tailored renewal of GHWL to avoid a waning impact
could be considered to maintain long-term efﬁcacy. Any
such approach should take into account the sociocul-
tural context of the targeted population by assessing
pre-existing awareness of smoking risks, as well as the
emotional impact of different GHWL. Finally, the length
of exposure to warning labels should be considered
when timing the launch of future public health interven-
tions. Future research should focus on this desensitisa-
tion effect with longitudinal studies.
Twitter Follow Culadeeban Ratneswaran at @Deeban8
Acknowledgements This work was partially supported by the National
Institute for Health Research (NIHR) Biomedical Research Centre based at
Guy’s and St Thomas’ NHS Foundation Trust and King’s College London.
Contributors CR designed the study, adapted the research items, established
and oversaw the London and Singapore research teams, obtained ethical
approval, and wrote all parts of the paper. He is the first guarantor. BC
collected and analysed the data, and made significant contribution to the
analysis section. ML and ST made significant contribution to the data
collection and literature review of the paper. AD guided the statistical analysis
and analysis section of the paper. DA established the project in Singapore,
oversaw the Singapore research team and critically reviewed the paper prior
to submission. JS is the second guarantor. He established the London
research arm, oversaw and safeguarded data collection, and guided, critically
reviewed and redrafted all aspects of the manuscript. All authors confirmed
the final draft prior to submission.
Funding JS’s contribution was partially supported by the National Institute
for Health Research (NIHR) Biomedical Research Centre based at Guy’s and
St Thomas’ NHS Foundation Trust and King’s College London. Open access
for this article was funded by King's College London.
Disclaimer The views expressed are those of the authors and not necessarily
those of the NHS, the NIHR or the Department of Health.
Competing interests None declared.
Ethics approval This study was approved by the local Research Ethics
Committee (12/NE/0013).
Data sharing statement All data are displayed. For further information, please
contact the lead author—CR (c.ratneswaran@gmail.com).
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Mendis S. Global status report on noncommunicable diseases
2014: World Health Organization (report number: 9789241564854),
2014. https://goo.gl/1UK96e (accessed 16 Oct 2016).
2. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of
burden of disease and injury attributable to 67 risk factors and risk
factor clusters in 21 regions, 1990–2010: a systematic analysis for
the Global Burden of Disease Study 2010. Lancet 2012;380:
2224–60.
3. World Health Organization. WHO global report: mortality attributable
to tobacco. 2012. http://www.who.int/tobacco/publications/
surveillance/rep_mortality_attributable/en/
4. Nasr SZ, Sweet SC. Electronic cigarette use in middle and high
school students triples from 2013 to 2014. Am J Respir Crit Care
Med 2015;192:276–8.
5. World Health Organization. WHO Framework convention on tobacco
control. Secondary WHO Framework convention on tobacco control.
http://www.who.int/fctc/en/ (accessed 06 Aug 2016).
6. Wakefield M, Morley C, Horan JK, et al. The cigarette pack as
image: new evidence from tobacco industry documents. Tob Control
2002;11(Suppl 1):i73–80.
7. Crotty Alexander L, Fuster M, Montgrain P, et al. The need for more
e-cigarette data: a call to action. Am J Respir Crit Care Med
2015;192:275–6.
8. West R. Smoking cessation interventions. In: Britton J, ed. Fifty
years since smoking and health: progress, lessons and priorities for
a smoke-free UK. UK: Royal College of Physicians, 2012:27–31.
9. Hammond D. Health warning messages on tobacco products:
a review. Tob Control 2011;20:327–37.
10. Vardavas CI, Connolly G, Karamanolis K, et al. Adolescents
perceived effectiveness of the proposed European graphic tobacco
warning labels. Eur J Public Health 2009;19:212–17.
11. Hammond D, Fong GT, McNeill A, et al. Effectiveness of cigarette
warning labels in informing smokers about the risks of smoking:
findings from the International Tobacco Control (ITC) Four Country
Survey. Tob Control 2006;15(Suppl 3):iii19–25.
12. Fong GT, Hammond D, Jiang Y, et al. Perceptions of tobacco health
warnings in China compared with picture and text-only health
warnings from other countries: an experimental study. Tob Control
2010;19(Suppl 2):i69–77.
13. Hammond D, Fong GT, McDonald PW, et al. Impact of the graphic
Canadian warning labels on adult smoking behaviour. Tob Control
2003;12:391–5.
14. Hammond D, Fong GT, Borland R, et al. Communicating risk to
smokers: the impact of health warnings on cigarette packages.
Am J Prev Med 2007;32:202.
15. Strasser AA, Tang KZ, Romer D, et al. Graphic warning labels in
cigarette advertisements: recall and viewing patterns. Am J Prev
Med 2012;43:41–7.
16. Borland R, Hill D. Initial impact of the new Australian tobacco health
warnings on knowledge and beliefs. Tob Control 1997;6:317–25.
17. McQueen A, Kreuter MW, Boyum S, et al. Reactions to
FDA-proposed graphic warning labels affixed to US smokers’
cigarette packs. Nicotine Tob Res 2015;17:784–95.
18. Borland R, Yong HH, Wilson N, et al. How reactions to cigarette
packet health warnings influence quitting: findings from the ITC
Four-Country survey. Addiction 2009;104:669–75.
19. Thrasher JF, Hammond D, Fong GT, et al. Smokers’ reactions to
cigarette package warnings with graphic imagery and with only text:
a comparison between Mexico and Canada. Salud Publica Mex
2007;49:S233.
20. Singapore Ministry of Health. Healthy living everyday: tobacco
control. Ministry of Health budget initiatives 2015 media fact sheets.
Press Room. https://goo.gl/2dGpP9 (accessed 16 Oct 2016).
21. European Commission. Commission Decision of 5 September 2003
on the use of colour photographs or other illustrations as health
warnings on tobacco packages. Official Journal of the European
Union 2003/641/EC. https://goo.gl/YpsyqW (accessed 16 Oct 2016).
22. Rooke S, Malouff J, Copeland J. Effects of repeated exposure to a
graphic smoking warning image. Curr Psychol 2012;31:282–90.
23. Miller CL, Hill DJ, Quester PG, et al. Impact on the Australian
quitline of new graphic cigarette pack warnings including the quitline
number. Tob Control 2009;18:235–7.
24. White V, Bariola E, Faulkner A, et al. Graphic health warnings on
cigarette packs: how long before the effects on adolescents wear
out? Nicotine Tob Res 2015;17:776–83.
Ratneswaran C, et al. BMJ Open 2016;6:e012693. doi:10.1136/bmjopen-2016-012693 7
Open Access
group.bmj.com on November 3, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
25. Borland R, Wilson N, Fong GT, et al. Impact of graphic and text
warnings on cigarette packs: findings from four countries over five
years. Tob Control 2009;18:358–64.
26. Ratneswaran C, Chisnall B, Drakatos P, et al. A cross-sectional
survey investigating the desensitisation of graphic health warning
labels and their impact on smokers, non-smokers and patients
with COPD in a London cohort. BMJ Open 2014;4:
e004782.
27. Ng DHL, Roxburgh STD, Sanjay S, et al. Awareness of smoking
risks and attitudes towards graphic health warning labels on
cigarette packs: a cross-cultural study of two populations in
Singapore and Scotland. Eye (Lond) 2010;24:864–8.
28. Moradi P, Thornton J, Edwards R, et al. Teenagers’ perceptions of
blindness related to smoking: a novel message to a vulnerable
group. Br J Ophthalmol 2007;91:605–7.
29. Hoth KF, Wamboldt FS, Bowler R, et al. Attributions about cause of
illness in chronic obstructive pulmonary disease. J Psychosom Res
2011;70:465–72.
30. World Health Organization. WHO Framework Convention on
Tobacco Control: Guidelines for Implementation of Article 5. 3 Article
8 Article 11 and Article 13. World Health Organization, 2009.
31. Blair MH. An empirical investigation of advertising wearin and
wearout. J Advertising Res 2000;40:95–100.
32. Bornstein RF. Exposure and affect: overview and meta-analysis of
research, 1968–1987. Psychol Bull 1989;106:265.
33. Strahan EJ, White K, Fong GT, et al. Enhancing the effectiveness of
tobacco package warning labels: a social psychological perspective.
Tob Control 2002;11:183–90.
34. Hammond D, Fong GT, Borland R, et al. Text and graphic
warnings on cigarette packages: findings from the international
tobacco control four country study. Am J Prev Med 2007;32:
202–9.
35. Tversky A, Kahneman D. Availability: a heuristic for judging
frequency and probability. Cogn Psychol 1973;5:207–32.
36. Wyer RS Jr, Hartwick J. The role of information retrieval and
conditional inference processes in belief formation and change.
Adv Exp Soc Psychol 1980;13:241–84.
37. Bohner G, Moskowitz GB, Chaiken S. The interplay of heuristic and
systematic processing of social information. Eur Rev Soc Psychol
1995;6:33–68.
38. Chen S, Chaiken S. The heuristic-systematic model in its broader
context. Dual Process Theories Soc Psychol 1999;15:73–96.
39. Zuckerman A, Chaiken S. A heuristic-systematic processing analysis
of the effectiveness of product warning labels. Psychol Mark
1998;15:621.
40. Fritzsche A, Watz H, Magnussen H, et al. Cognitive biases in
patients with chronic obstructive pulmonary disease and depression
—a pilot study. Br J Health Psychol 2013;18:827–43.
41. Rusanen M, Ngandu T, Laatikainen T, et al. Chronic obstructive
pulmonary disease and asthma and the risk of mild cognitive
impairment and dementia: a population based CAIDE study.
Curr Alzheimer Res 2013;10:549–55.
42. Martinez CH, Richardson CR, Han MK, et al. Chronic obstructive
pulmonary disease, cognitive impairment, and development of
disability: the Health and Retirement Study. Ann Am Thorac Soc
2014;11:1362–70.
43. Chronic Obstructive Pulmonary Disease and Association with Mild
Cognitive Impairment: the Mayo Clinic Study of Aging. Mayo Clinic
Proc 2013;88:1222–30.
44. Singh B, Mielke MM, Parsaik AK, et al. A prospective study of
chronic obstructive pulmonary disease and the risk for mild cognitive
impairment. JAMA Neurol 2014;71:581–8.
45. Steptoe A, Wardle J, Smith H, et al. Tobacco smoking in young
adults from 21 European countries: association with attitudes and
risk awareness. Addiction 1995;90:571–82.
46. Hammond D. Tobacco Labelling Resource Centre. Secondary
Tobacco Labelling Resource Centre, 2015. http://www.tobaccolabels.
ca/. Last accessed 06/08/2016
47. Bidwell G, Sahu A, Edwards R, et al. Perceptions of blindness
related to smoking: a hospital-based cross-sectional study.
Eye (Lond) 2005;19:945–8.
48. World Health Organization. World No Tobacco Day, 31 May 2016:
Get ready for plain packaging, 2016. World Health Organization
news releases. https://goo.gl/oMHm2P (accessed 16 Oct 2016).
8 Ratneswaran C, et al. BMJ Open 2016;6:e012693. doi:10.1136/bmjopen-2016-012693
Open Access
group.bmj.com on November 3, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
between London and Singapore
health warnings: a cohort comparison 
Desensitisation to cigarette package graphic
Douiri, Devanand Anantham and Joerg Steier
Culadeeban Ratneswaran, Ben Chisnall, Mingyue Li, Sarah Tan, Abdel
doi: 10.1136/bmjopen-2016-012693
2016 6: BMJ Open 
 http://bmjopen.bmj.com/content/6/10/e012693
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/6/10/e012693
This article cites 39 articles, 15 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (212)Smoking and tobacco
 (370)Global health
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on November 3, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
